Expertise in
9
conditions

Mikael Sundin

Intervention And Technology, Karolinska Institutet
Stockholm, AB, SE 
Expertise in
9
conditions
Intervention And Technology, Karolinska Institutet
Stockholm, AB, SE 
OverviewLocationsClinical Research

Overview

Mikael Sundin practices in Stockholm, Sweden. Mr. Sundin is highly rated in 9 conditions, according to our data. His top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Severe Combined Immunodeficiency (SCID), Dyskeratosis Congenita, Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 84 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Intervention and Technology, Karolinska Institutet
Stockholm, AB, Sweden
Other Locations
Solna, AB, Sweden
Huddinge, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Radiation- and Alkylator-free Hematopoietic Cell Transplantation for Bone Marrow Failure Due to Dyskeratosis Congenita / Telomere Disease
Radiation- and Alkylator-free Hematopoietic Cell Transplantation for Bone Marrow Failure Due to Dyskeratosis Congenita / Telomere Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2025
Intervention Type: Drug, Biological
Study Drugs: Alemtuzumab, Fludarabine, Cyclosporine, Mycophenolate Mofetil
Study Phase: Phase 2
An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls
An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls
Enrollment Status: Active_not_recruiting
Publish Date: March 07, 2024
Intervention Type: Biological
Study Drug: BOOST cells
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

84 Total Publications

Leukopenia in Children on Antiseizure Medication is Common and Has Minor Clinical Impact.
Leukopenia in Children on Antiseizure Medication is Common and Has Minor Clinical Impact.
Journal: The Journal of pediatrics
Published: February 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sundin's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile